Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

15.43 -0.55 (-3.44%)
Official Closing Price Updated: 7:00 PM EDT, Aug 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,904,221
Open 16.10
Bid (Size) 15.40 (1)
Ask (Size) 15.42 (1)
Prev. Close 15.98
Today's Range 15.41 - 16.20
52wk Range 5.650 - 25.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hims & Hers Health Unusual Options Activity For August 13
Via Benzinga
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
A company's investments can easily ruin the plans of its competitors. 
Via The Motley Fool

Performance

YTD
+60.06%
+60.06%
1 Month
-32.44%
-32.44%
3 Month
+11.49%
+11.49%
6 Month
+54.45%
+54.45%
1 Year
+114.90%
+114.90%

More News

Read More
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
Via MarketBeat
Topics Stocks
Exposures US Equities
Hims & Hers Health Boosts Outlook. Is This a Golden Opportunity to Buy the Stock?
Via The Motley Fool
MarketBeat Week in Review – 8/5 - 8/9
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Analyst Expectations For Hims & Hers Health's Future
Via Benzinga
How Is The Market Feeling About Hims & Hers Health?
Via Benzinga
Hims & Hers Stock Crashed but This Is a Growth Machine
Via The Motley Fool
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
Via MarketBeat
Topics Bonds ETFs
Exposures Debt Markets
HIMS Stock Earnings: Hims & Hers Health Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Hims & Hers Health Reports Better-Than-Expected Q2 Results: Details
Via Benzinga
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
From Hims & Hers
Via Business Wire
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Via InvestorPlace
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Via MarketBeat
Hims & Hers Stock Is Looking to Cash in From the GLP-1 Hype, but Will Its Controversial Strategy Pay Off?
Via The Motley Fool
What's Going On With HIMS Shares Today?
Via Benzinga
Got $200? 2 Best Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Marker Rotation Is In Full Gear
Via Talk Markets
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
3 Game-Changing Stocks on the Edge of Unprecedented Gains
Via InvestorPlace
Can the New CEO Revive This Struggling Telehealth Stock?
Via MarketBeat
Topics Earnings
Exposures Financial
3 Once-in-a-Lifetime Stock Opportunities You Can’t Miss: July 2024
Via InvestorPlace
What's Going On With Hims & Hers Shares Today?
Via Benzinga
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Hims & Hers Heath Shares Are Surging Today
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.